HMGB1 and colorectal carcinoma: Our study revealed that the HMGB1/ZNF460/BECN1 axis contributes to radioresistance and autophagy in CRC, suggesting that HMGB1 could be a potential therapeutic target for enhancing the response of CRC to radiation therapy.